"OMRON receives FDA authorisation for blood pressure monitors with AFib feature" was originally created and published by ...

In a pivotal stride to address the growing AFib epidemic, OMRON Healthcare today announced the U.S. Food and Drug ...

The FDA has granted a de novo clearance to a wearable device—with a form factor you’re familiar with—that can check patients ...

New research indicates that 1 hour of moderate exercise per week can help prevent atrial fibrillation (AFib). While a small ...

Outdoor temperatures that reach or exceed 100 degrees Fahrenheit nearly tripled the number of episodes of an irregular heart ...

The REACT-AF trial began in July 2023 and is led by researchers at Johns Hopkins Medicine. Randomized patients (half of the ...

Boston Scientific expects to complete enrollment in the coming months in the study comparing pulsed field ablation to ...

OMRON Healthcare has received de novo authorization from the U.S. Food and Drug Administration (FDA) to market new home blood pressure monitors featuring AI-powered atrial fibrillation ...

Late last month, Boston Scientific announced it was pausing a study examining pulsed field ablation as a first-line therapy.

‘We are at a crossroads’: Prince Harry and Meghan Markle issue new video message Political Novice Levi Strauss Heir Defeats ...

Acutus Medical, Inc. (“Acutus” or the “Company”) (OTC: AFIB) today reported results for the third quarter and year-to-date of 2024. Recent Highlights: Third quarter revenue from Continuing Operations ...

In a report released today, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Milestone Pharmaceuticals (MIST – Research ...